Dingxie Liu

1 Patent

• US116802972023

  Activities of Multiple Cancer-related Pathways Are Associated with BRAF Mutation and Predict the Resistance to BRAF/MEK Inhibitors in Melanoma Cells

  THE JOHNS HOPKINS UNIVERSITY

  0 cites